25589-41-7 Usage
Description
4-[(4-bromophenyl)amino]-4-oxobutanoic acid is a chemical compound with the molecular formula C10H10BrNO3. It is a derivative of butanoic acid, featuring a 4-oxo group and a 4-bromophenylamino group. 4-[(4-bromophenyl)amino]-4-oxobutanoic acid is known for its unique molecular structure and reactivity, which makes it a valuable component in the synthesis of pharmaceuticals and organic compounds.
Uses
Used in Pharmaceutical Synthesis:
4-[(4-bromophenyl)amino]-4-oxobutanoic acid is used as a key intermediate in the synthesis of various pharmaceuticals. Its structural properties and reactivity contribute to the development of new drugs with potential therapeutic applications.
Used in Organic Compounds Synthesis:
4-[(4-bromophenyl)amino]-4-oxobutanoic acid is also utilized in the synthesis of organic compounds, where its unique molecular structure plays a crucial role in creating novel chemical entities with specific properties and functions.
Used in Medical Field:
Due to its potential applications, 4-[(4-bromophenyl)amino]-4-oxobutanoic acid is being explored for use in the medical field. Its structural properties may contribute to the development of new therapeutic agents with improved efficacy and safety profiles.
Used in Specialty Chemicals and Materials Production:
4-[(4-bromophenyl)amino]-4-oxobutanoic acid may also find uses in the production of specialty chemicals and materials, where its unique molecular structure can be leveraged to create innovative products with specific applications across various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 25589-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,5,8 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 25589-41:
(7*2)+(6*5)+(5*5)+(4*8)+(3*9)+(2*4)+(1*1)=137
137 % 10 = 7
So 25589-41-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H10BrNO3/c11-7-1-3-8(4-2-7)12-9(13)5-6-10(14)15/h1-4H,5-6H2,(H,12,13)(H,14,15)
25589-41-7Relevant articles and documents
N-Aryl Amides as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Contrast Agents
Cai, Xuekang,Zhang, Jia,Lu, Jiaqi,Yi, Long,Han, Zheng,Zhang, Shuixing,Yang, Xing,Liu, Guanshu
supporting information, p. 11705 - 11709 (2020/08/13)
Chemical exchange saturation transfer (CEST) MRI has recently emerged as a versatile molecular imaging approach in which diamagnetic compounds can be utilized to generate an MRI signal. To expand the scope of CEST MRI applications, herein, we systematical
Radical-mediated dehydrative preparation of cyclic imides using (NH4)2S2O8-DMSO: Application to the synthesis of vernakalant
Garad, Dnyaneshwar N.,Tanpure, Subhash D.,Mhaske, Santosh B.
supporting information, p. 1008 - 1016 (2015/08/18)
Ammonium persulfate-dimethyl sulfoxide (APS-DMSO) has been developed as an efficient and new dehydrating reagent for a convenient one-pot process for the synthesis of miscellaneous cyclic imides in high yields starting from readily available primary amines and cyclic anhydrides. A plausible radical mechanism involving DMSO has been proposed. The application of this facile one-pot imide forming process has been demonstrated for a practical synthesis of vernakalant.
A facile and green synthesis of N-substituted imides
Kumar, Padam Praveen,Rama Devi,Dubey
, p. 1166 - 1171 (2013/09/24)
Anhydrides 1, 6 and 10 have been reacted, independently, with aromatic primary amines 2 in solid phase by simple physical grinding of reactants with p-toluenesulphonicacid as a catalyst to yield corresponding open chain derivatives, monoacid monoamides3,7 and 11 respectively. The latter have each been transformed into the corresponding cyclic derivatives, i.e. imides 5, 9 and 13 respectively in solid phase by simple physical grinding of each with K 2CO3, alkylating agent and tetrabutylammoniumbromide as a catalyst with short reaction times. These cyclic imides can also be obtained by physical grinding of each of 3, 7 and 11 with dicyclohexylcarbodimide as a dehydrating agent in solid phase.
